Personalized Medicine Beyond Genomics: New Technologies, Global Health Diplomacy and Anticipatory Governance.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Historical evolution of cancer genomics research in Latin America: a comprehensive visual and bibliometric analysis until 2023.Frontiers in genetics · 2024
   Article
2. Personalized medicine, digital technology and trust: a Kantian account.Medicine, health care, and philosophy · 2020
   Article
3. Anticipatory governance for social-ecological resilience.Ambio · 2015
   Article
4. Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics).Omics : a journal of integrative biology · 2014
   Article
5. Designing a post-genomics knowledge ecosystem to translate pharmacogenomics into public health action.Genome medicine · 2012
   Article
6. Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.Current pharmacogenomics and personalized medicine · 2011
   Article
7. Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health.Current pharmacogenomics and personalized medicine · 2011
   Article
8. Global Health Governance at a Crossroads.Global health governance : the scholarly journal for the new health security paradigm · 2011
   Article
9. Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine.Current pharmacogenomics and personalized medicine · 2011
   Article
10. Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value.Current pharmacogenomics and personalized medicine · 2010
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors.

Funding

Abstract

PubMed holds no abstract for this paper.